Long-Term Sequelae of SARS-COV-2 Infection: Diabetes Mellitus

Completed

Conditions studied: COVID-19, Diabete Mellitus

In brief

Hospitalized patients with severe COVID-19 have an increased incidence of insulin resistance, impaired beta cell function, glucose intolerance (prediabetes), and overt type 2 diabetes (T2D) compared to non-hospitalized patients with COVID-19 and COVID-19 negative individuals on long-term follow up.

Key facts

Study ID

NCT05867017

Run by

The University of Texas Health Science Center at San Antonio

People needed

23

Starts

2023-07-10

Expected to finish

2025-11-30

Last updated by the study team

2026-01-07

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Body Mass index (BMI) < 40 kg/m2

You may not qualify if…

• History of diabetes prior to SARS-CoV-2 infection
• Took medications used to treat diabetes prior to SARS-CoV-2 infection
• History of myocardial infarction or stroke within 6 months
• History of major organ system disease prior to COVID-19 infection

Where it is running

• Texas Diabetes Institute - University Health System — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.